Will an adult born on [DATE_OF_BIRTH] experience pain or significant side effects from receiving another dose of the measles‑mumps‑rubella (MMR) vaccine?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Will Getting Another MMR Vaccine Hurt?

No, receiving another dose of MMR vaccine will not cause significant harm—the most common side effect is temporary pain at the injection site, and serious adverse events are extremely rare in adults. 1

Expected Side Effects

Common Local and Systemic Reactions

The most frequently reported side effects after MMR vaccination in adults are mild and self-limited 1:

  • Injection site pain occurs most commonly but resolves quickly 1
  • Fever affects approximately 19% of adult vaccinees 2
  • Rash develops in about 17% of recipients 2
  • Joint pain (arthralgia) occurs in roughly 13% of adults, with an incidence of 263 per 100,000 doses 3, 2
  • Headache was reported by 13% of young adults receiving a third MMR dose 4

Duration and Onset

When systemic symptoms occur, they typically 4:

  • Begin 3-6 days after vaccination
  • Last only 1-2 days
  • Resolve without intervention

Serious Adverse Events Are Extremely Rare

The risk of serious complications from MMR vaccination in adults is negligible 3:

  • Serious adverse events occurred in only 5% of all reports to the Vaccine Adverse Event Reporting System, with an incidence of ≤6 per 100,000 doses for any specific serious outcome 3, 2
  • Anaphylaxis is extremely rare—only 33 cases were reported after more than 70 million MMR doses distributed in the United States 5
  • No significant elevation in risk was found for encephalitis, seizures, Guillain-Barré syndrome, or meningitis during post-vaccination risk windows compared to control periods 3

Specific Rare Risks

Two conditions have documented associations with MMR vaccination, but both carry minimal clinical significance 6:

  • Febrile seizures: Attributable risk of 1 per 1,150 to 1 per 1,700 doses (note: febrile seizures naturally occur in 2-4% of healthy children under age 5) 6
  • Immune thrombocytopenic purpura (ITP): Attributable risk of approximately 1 per 40,000 doses—notably lower than the ITP risk from natural measles, mumps, or rubella infection 6

Safety of Additional Doses

Receiving a third dose of MMR is safe and well-tolerated 4:

  • A study of 662 young adults receiving a third MMR dose found that only 18% experienced more symptoms after vaccination than at baseline 4
  • Only one healthcare visit was required for a potential vaccine-related symptom (urticaria) among all participants 4
  • All reported events were mild and transient 4

Who Should Avoid MMR

Do not receive MMR if you 1:

  • Are pregnant or planning pregnancy within the next month
  • Have a severely weakened immune system (including high-dose steroid therapy)
  • Have active untreated tuberculosis
  • Have a history of severe allergic reaction to gelatin or neomycin
  • Currently have a high fever

Clinical Context for Your Birth Year

If you were born in 1957 or later, you should have documentation of at least one MMR dose unless you have laboratory evidence of immunity 5. Persons born before 1957 are generally considered immune to measles and mumps and do not require vaccination 5.

Receiving an extra dose of MMR when immunity status is uncertain poses no additional safety risk—there is no harm from "over-vaccination" with MMR 4. The vaccine cannot cause measles, mumps, or rubella infection because it contains only weakened (attenuated) viruses 1.

References

Research

Adverse Events Following Measles, Mumps, and Rubella Vaccine in Adults Reported to the Vaccine Adverse Event Reporting System (VAERS), 2003-2013.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015

Research

Adverse Events Among Young Adults Following a Third Dose of Measles-Mumps-Rubella Vaccine.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Vaccines for measles, mumps, rubella, and varicella in children.

The Cochrane database of systematic reviews, 2020

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.